top of page

Still unsure...let's chat!!

Psychedelic therapy is proven to be 3x more effective and 10x cheaper than traditional therapy

Image by . liane .

Image by . liane .

A review of the non-medical use of ketamine, Journal of Psychoactive Drugs
Fact Sheet on Ketamine, Center for Substance Abuse Research
DEA Fact Sheet on Ketamine, Drug Enforcement Agency

Bipolar Disorder: Safety and Tolerability of Ketamine Use in Treatment-Resistant Bipolar Depression Patients with Regard to Central Nervous System Symptomatology: Literature Review and Analysis, Medicina 2020
Substance Abuse Disorder: Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review, Frontiers in Psychiatry 2018
PTSD: A Systematic Review on the Efficacy of Intravenous Racemic Ketamine for Bipolar Depression. Journal of Clinical Psychopharmacology, 2021
Suicidal Thoughts: Ketamine for suicidal ideation in adults with psychiatric disorders: A systemic review and meta-analysis of treatment trials Au and Nz Journal of Psychiatry 2019
Anxiety Disorder: Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature, CNS Spectrums 2019
Pain disorders: Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management, Regional Anesthesia and Pain Medicine 2018

Elemental: Ketamine Is Revealing a New Understanding of Depression and the Brain
Medical News Today: Ketamine infusions may reduce the severity of PTSD symptoms
Psychology Today: IV Ketamine for Treatment-Resistant Depression
Gizmodo: More Than Just a Trip: Why Does Ketamine Work for Depression When Nothing Else Does?
Mindbodygreen: I Tried Ketamine Therapy For Anxiety & This Was My Experience

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders, JAMA Psychiatry 2017
Intravenous Ketamine for Adults With Treatment-Resistant Depression or Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines, Canadian Agency for Drugs and Technologies in Health 2019

Registered Clinical Trials Investigating Ketamine for Psychiatric Disorders, Journal of Psychiatric Research 2020
Ketamine for Treatment-Resistant Mood Disorders, Focus 2020
The Relationship Between Subjective Effects Induced by a Single Dose of Ketamine and Treatment Response in Patients With Major Depressive Disorder: A Systematic Review, Journal of Affect Disorders 2020
Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis, Journal of Affective Disorders 2020
Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine, Progress in Neuro-Psychopharmacology and Biological Psychiatry 2020
Cardiovascular effects of repeated subanaesthetic ketamine infusion in depression, Journal of Psychopharmacology 2020
Antidepressant and Neurocognitive Effects of Serial Ketamine Administration Versus ECT in Depressed Patients, Journal of Psychiatric Research 2020
Ketamine Normalizes Subgenual Cingulate Cortex Hyper-Activity in Depression, Neuropsychopharmacology 2020
Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression, Biological Psychiatry 2019
Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression, Psychotherapy and Psychosomatics 2017
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD), Nature 2018
Maintenance Ketamine Therapy for Treatment-Resistant Depression, Journal of Clinical Psychopharmacology 2018

Ketamine Wikipedia Entry
Ketamine Manufacturer Data Sheet, Pfizer
W.H.O. F a ct Sheet, World Health Organization
History of Anesthesia: The Ketamine Story – past, present and future, European Journal of Anesthesiology

bottom of page